Innate Immune Responses to Bacterial Ligands in the Human Lung
Author Information
Author(s): Thorley Andrew J., Grandolfo Davide, Lim Eric, Goldstraw Peter, Young Alan, Tetley Teresa D.
Primary Institution: Imperial College, London, United Kingdom
Hypothesis
Human alveolar type I (ATI) and type II (ATII) epithelial cells are responsive to TLR2 and TLR4 ligands and express the necessary TLRs and co-receptors.
Conclusion
This study shows that human alveolar epithelial cells can respond to TLR2 and TLR4 ligands, indicating their role in the innate immune response.
Supporting Evidence
- Primary human ATII cells and ATI cells express CD14 and respond to TLR ligands.
- LPS exposure leads to significant cytokine release from alveolar macrophages and ATII cells.
- TT1 cells, an immortalized ATI cell line, also respond to TLR ligands but with different cytokine profiles.
- Serum enhances the response to LPS but not to MALP-2.
- MAP kinases play a significant role in cytokine release following TLR activation.
Takeaway
The cells in our lungs can recognize and respond to germs, helping to protect us from infections.
Methodology
The study involved isolating primary human alveolar macrophages and type II epithelial cells, exposing them to TLR ligands, and measuring cytokine release.
Potential Biases
Potential bias due to the use of a specific cell line and the limited sample size.
Limitations
The study primarily focused on specific cell types and may not represent all aspects of the immune response in the lung.
Participant Demographics
Samples were obtained from lung tissue following resection for lung carcinoma.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website